Pacira Pharmaceuticals, Inc. Reports First Quarter EXPAREL Revenues of $56.0 Million and First Quarter 2015 Financial Results

Go back to Pacira Pharmaceuticals, Inc. Reports First Quarter EXPAREL Revenues of $56.0 Million and First Quarter 2015 Financial Results
PACIRA (NASDAQ: PCRX) Delayed: 26.47 +0.88 (3.44%)
Previous Close $25.59    52 Week High $80.25 
Open $25.85    52 Week Low $30.25 
Day High $26.66    P/E N/A 
Day Low $25.34    EPS $-2.08 
Volume 142,048